Webster L, Stanbury R M, Chignell A H, Limb G A
Department of Ophthalmology, Rayne Institute, UMDS, St Thomas's Hospital, London.
Br J Ophthalmol. 1998 Apr;82(4):438-43. doi: 10.1136/bjo.82.4.438.
The vitreous levels of soluble intercellular adhesion molecule 1 (sICAM-1) were investigated in uveitic eyes undergoing vitrectomy for retinal detachment (RD) or other complications, and the presence of this molecule was related to disease activity and vitreous levels of the cytokine tumour necrosis factor alpha (TNF alpha), known to upregulate ICAM-1 expression on various cells.
Vitreous and serum samples from 23 patients with either active or quiescent uveitis undergoing retinal surgery were examined for the levels of immunoreactive sICAM-1 and TNF alpha by ELISA methods, and for the presence of biologically active TNF alpha. Vitreous from non-uveitic eyes with rhegmatogenous retinal detachment (RRD), macular holes or cadaveric eyes were used as controls.
As a whole, vitreous from uveitic eyes complicated or uncomplicated by RRD contained significantly higher levels of sICAM-1 than vitreous from non-uveitic eyes with RRD alone (p < 0.0005), eyes with macular holes (p < 0.0001), or normal cadaveric vitreous (p < 0.0001). The proportion of vitreous containing > 20 ng/ml sICAM-1 (> four times the normal values) was significantly higher in eyes with uveitis complicated by RRD than in those eyes without RRD (Fisher's test, p = 0.02), and although levels of sICAM-1 were higher in eyes with active uveitis than in those with quiet disease (p < 0.02), this could not be dissociated from the increase caused by RRD. There was a relation between the vitreous levels of sICAM-1 and those of immunoreactive TNF alpha (Spearman's correlation coefficient; r = 0.601, p = 0.006), but not between the vitreous levels of sICAM-1 and those of biologically active TNF alpha.
Increased vitreous sICAM-1 levels and the association of this molecule with the presence of immunoreactive TNF alpha in uveitic eyes confirm the operation of cytokine mediated vascular reactions at the blood-retinal barrier during the development of this condition. The persistence of high vitreous levels of sICAM-1 in eyes with uveitis complicated by RRD despite previous immunosuppression may indicate a low rate of clearance of inflammatory molecules from the vitreous cavity and an exacerbation of the existing inflammatory process by the retinal detachment itself.
研究因视网膜脱离(RD)或其他并发症而接受玻璃体切除术的葡萄膜炎患者玻璃体中可溶性细胞间黏附分子1(sICAM - 1)的水平,并探讨该分子的存在与疾病活动度以及细胞因子肿瘤坏死因子α(TNFα)玻璃体水平之间的关系,已知TNFα可上调多种细胞上ICAM - 1的表达。
采用酶联免疫吸附测定(ELISA)法检测23例接受视网膜手术的活动性或静止性葡萄膜炎患者的玻璃体和血清样本中免疫反应性sICAM - 1和TNFα的水平,并检测生物活性TNFα的存在情况。将孔源性视网膜脱离(RRD)、黄斑裂孔或尸体眼的非葡萄膜炎性玻璃体作为对照。
总体而言,合并或未合并RD的葡萄膜炎患者玻璃体中sICAM - 1水平显著高于单纯RRD的非葡萄膜炎患者玻璃体(p < 0.0005)、黄斑裂孔患者玻璃体(p < 0.0001)或正常尸体玻璃体(p < 0.0001)。合并RD的葡萄膜炎患者玻璃体中sICAM - 1含量>20 ng/ml(>正常值4倍)的比例显著高于未合并RD的患者(Fisher检验,p = 0.02),尽管活动性葡萄膜炎患者玻璃体中sICAM - 1水平高于静止期患者(p < 0.02),但这与RD导致的升高无法区分。玻璃体中sICAM - 1水平与免疫反应性TNFα水平之间存在相关性(Spearman相关系数;r = 0.601,p = 0.006),但玻璃体中sICAM - 1水平与生物活性TNFα水平之间无相关性。
葡萄膜炎患者玻璃体中sICAM - 1水平升高以及该分子与免疫反应性TNFα存在的关联,证实了在该疾病发生过程中细胞因子介导的血视网膜屏障血管反应的作用。尽管先前进行了免疫抑制,但合并RD的葡萄膜炎患者玻璃体中sICAM - 1水平持续升高,这可能表明玻璃体腔中炎症分子的清除率较低,且视网膜脱离本身会加剧现有的炎症过程。